Biomea Fusion Statistics

Total Valuation

Biomea Fusion has a market cap or net worth of $320.35 million. The enterprise value is $249.21 million.

Market Cap	320.35M
Enterprise Value	249.21M

Important Dates

The last earnings date was Tuesday, October 29, 2024, after market close.

Earnings Date	Oct 29, 2024
Ex-Dividend Date	n/a

Share Statistics

Biomea Fusion has 36.24 million shares outstanding. The number of shares has increased by 10.63% in one year.

Shares Outstanding	36.24M
Shares Change (YoY)	+10.63%
Shares Change (QoQ)	+0.49%
Owned by Insiders (%)	12.70%
Owned by Institutions (%)	54.25%
Float	22.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.31
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.39, with a Debt / Equity ratio of 0.13.

Current Ratio	3.39
Quick Ratio	3.19
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -104.51% and return on invested capital (ROIC) is -63.64%.

Return on Equity (ROE)	-104.51%
Return on Assets (ROA)	-56.38%
Return on Capital (ROIC)	-63.64%
Revenue Per Employee	n/a
Profits Per Employee	-$1.40M
Employee Count	103
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.39% in the last 52 weeks. The beta is -0.43, so Biomea Fusion's price volatility has been lower than the market average.

Beta (5Y)	-0.43
52-Week Price Change	-12.39%
50-Day Moving Average	9.45
200-Day Moving Average	10.67
Relative Strength Index (RSI)	37.04
Average Volume (20 Days)	843,469

Short Selling Information

The latest short interest is 8.19 million, so 22.59% of the outstanding shares have been sold short.

Short Interest	8.19M
Short Previous Month	7.93M
Short % of Shares Out	22.59%
Short % of Float	36.46%
Short Ratio (days to cover)	8.43

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-151.32M
Pretax Income	-139.65M
Net Income	-144.01M
EBITDA	-149.63M
EBIT	-151.32M
Earnings Per Share (EPS)	-$4.00

Full Income Statement

Balance Sheet

The company has $87.95 million in cash and $9.57 million in debt, giving a net cash position of $78.39 million or $2.16 per share.

Cash & Cash Equivalents	87.95M
Total Debt	9.57M
Net Cash	78.39M
Net Cash Per Share	$2.16
Equity (Book Value)	75.97M
Book Value Per Share	2.10
Working Capital	66.03M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$112.73 million and capital expenditures -$288,000, giving a free cash flow of -$113.02 million.

Operating Cash Flow	-112.73M
Capital Expenditures	-288,000
Free Cash Flow	-113.02M
FCF Per Share	-$3.12

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Biomea Fusion does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.63%
Shareholder Yield	-10.63%
Earnings Yield	-43.96%
FCF Yield	-34.50%

Analyst Forecast

The average price target for Biomea Fusion is $37.25, which is 321.38% higher than the current price. The consensus rating is "Buy".

Price Target	$37.25
Price Target Difference	321.38%
Analyst Consensus	Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1